Logo image of IVVD

INVIVYD INC (IVVD) Stock Fundamental Analysis

USA - NASDAQ:IVVD - US00534A1025 - Common Stock

1.585 USD
+0.04 (+2.92%)
Last: 11/7/2025, 8:00:02 PM
1.61 USD
+0.03 (+1.58%)
Pre-Market: 11/10/2025, 7:28:25 AM
Fundamental Rating

3

Overall IVVD gets a fundamental rating of 3 out of 10. We evaluated IVVD against 531 industry peers in the Biotechnology industry. IVVD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IVVD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year IVVD has reported negative net income.
IVVD had a negative operating cash flow in the past year.
In the past 5 years IVVD always reported negative net income.
IVVD had a negative operating cash flow in each of the past 5 years.
IVVD Yearly Net Income VS EBIT VS OCF VS FCFIVVD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

IVVD has a Return On Assets (-43.02%) which is in line with its industry peers.
The Return On Equity of IVVD (-64.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -43.02%
ROE -64.32%
ROIC N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
IVVD Yearly ROA, ROE, ROICIVVD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

IVVD has a better Gross Margin (93.34%) than 93.03% of its industry peers.
The Profit Margin and Operating Margin are not available for IVVD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVVD Yearly Profit, Operating, Gross MarginsIVVD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

IVVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IVVD has been increased compared to 1 year ago.
IVVD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IVVD Yearly Shares OutstandingIVVD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
IVVD Yearly Total Debt VS Total AssetsIVVD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -5.72, we must say that IVVD is in the distress zone and has some risk of bankruptcy.
IVVD has a worse Altman-Z score (-5.72) than 63.28% of its industry peers.
IVVD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.72
ROIC/WACCN/A
WACC8.75%
IVVD Yearly LT Debt VS Equity VS FCFIVVD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

IVVD has a Current Ratio of 2.47. This indicates that IVVD is financially healthy and has no problem in meeting its short term obligations.
IVVD has a Current ratio of 2.47. This is in the lower half of the industry: IVVD underperforms 68.93% of its industry peers.
A Quick Ratio of 2.47 indicates that IVVD has no problem at all paying its short term obligations.
The Quick ratio of IVVD (2.47) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
IVVD Yearly Current Assets VS Current LiabilitesIVVD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.47% over the past year.
IVVD shows a strong growth in Revenue. In the last year, the Revenue has grown by 332.71%.
EPS 1Y (TTM)73.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)332.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.17%

3.2 Future

Based on estimates for the next years, IVVD will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.25% on average per year.
IVVD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 76.25% yearly.
EPS Next Y69.88%
EPS Next 2Y37.58%
EPS Next 3Y26.71%
EPS Next 5Y17.25%
Revenue Next Year99.95%
Revenue Next 2Y124.25%
Revenue Next 3Y107.71%
Revenue Next 5Y76.25%

3.3 Evolution

IVVD Yearly Revenue VS EstimatesIVVD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IVVD Yearly EPS VS EstimatesIVVD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IVVD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IVVD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVVD Price Earnings VS Forward Price EarningsIVVD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVVD Per share dataIVVD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

IVVD's earnings are expected to grow with 26.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.58%
EPS Next 3Y26.71%

More info and screens

0

5. Dividend

5.1 Amount

IVVD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INVIVYD INC

NASDAQ:IVVD (11/7/2025, 8:00:02 PM)

Premarket: 1.61 +0.03 (+1.58%)

1.585

+0.04 (+2.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-18 2026-03-18/amc
Inst Owners60.72%
Inst Owner ChangeN/A
Ins Owners3.49%
Ins Owner Change1.29%
Market Cap331.87M
Revenue(TTM)50.04M
Net Income(TTM)-59.86M
Analysts82.22
Price Target5.78 (264.67%)
Short Float %9.85%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-188.9%
Min EPS beat(2)-404.27%
Max EPS beat(2)26.47%
EPS beat(4)2
Avg EPS beat(4)-183.34%
Min EPS beat(4)-404.27%
Max EPS beat(4)26.47%
EPS beat(8)3
Avg EPS beat(8)-102.69%
EPS beat(12)5
Avg EPS beat(12)-65.84%
EPS beat(16)8
Avg EPS beat(16)-46.19%
Revenue beat(2)0
Avg Revenue beat(2)-25.93%
Min Revenue beat(2)-50.11%
Max Revenue beat(2)-1.74%
Revenue beat(4)0
Avg Revenue beat(4)-29.95%
Min Revenue beat(4)-67.83%
Max Revenue beat(4)-0.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)88.89%
PT rev (3m)14.87%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)-900%
EPS NY rev (1m)-14.29%
EPS NY rev (3m)-915.46%
Revenue NQ rev (1m)-7.09%
Revenue NQ rev (3m)-54.84%
Revenue NY rev (1m)-4.82%
Revenue NY rev (3m)-54.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.63
P/FCF N/A
P/OCF N/A
P/B 3.57
P/tB 3.57
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.38
OCFYN/A
SpS0.24
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.02%
ROE -64.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.34%
FCFM N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.58%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z -5.72
F-Score5
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)1470.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y69.88%
EPS Next 2Y37.58%
EPS Next 3Y26.71%
EPS Next 5Y17.25%
Revenue 1Y (TTM)332.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.17%
Revenue Next Year99.95%
Revenue Next 2Y124.25%
Revenue Next 3Y107.71%
Revenue Next 5Y76.25%
EBIT growth 1Y73.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.3%
EBIT Next 3Y29.01%
EBIT Next 5Y17.82%
FCF growth 1Y50.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.23%
OCF growth 3YN/A
OCF growth 5YN/A

INVIVYD INC / IVVD FAQ

What is the fundamental rating for IVVD stock?

ChartMill assigns a fundamental rating of 3 / 10 to IVVD.


What is the valuation status of INVIVYD INC (IVVD) stock?

ChartMill assigns a valuation rating of 1 / 10 to INVIVYD INC (IVVD). This can be considered as Overvalued.


How profitable is INVIVYD INC (IVVD) stock?

INVIVYD INC (IVVD) has a profitability rating of 1 / 10.


What is the earnings growth outlook for INVIVYD INC?

The Earnings per Share (EPS) of INVIVYD INC (IVVD) is expected to grow by 69.88% in the next year.